Abstract:Background Endometrial carcinoma is one of the most common female tract genital malignant tumors. Nifedipine, an L-type calcium channel antagonist can inhibit cell proliferation of carcinomas. Recent studies indicated that a rise in the free cytosolic calcium ([Ca2+](c)) was a potent inducer of autophagy. Here, we investigated the relationship between nifedipine and autophagy in Hec-1A cells.Methods Cells were cultured with nifedipine (10 mu mol/L) and harvested at different times for counting cell number. MTT assay was applied to evaluate the cell viability and transwell assay to reveal cell migration. Apoptotic cells were detected with annexin V/PI assay. Then cells were treated with 3-methyladenine (3-MA) (2.5 mmol/L) for 0, 5, 15, 30, 60, and 120 minutes and the expression of the L-type calcium channel alpha1D (Cav1.3) protein was detected. At last, cells were cultured and assigned to four groups with different treatment: untreated (control group), 10 mu mol/L nifedipine (N group), 2.5 mmol/L 3-MA (3-MA group), and 10 mu mol/L nifedipine plus 2.5 mmol/L 3-MA (N+3MA group). Autophagy was detected with GFP-LC3 modulation by fluorescent microscopy, and expression of the autophagy-associated proteins (LC3, Beclin1 and P70s6K) by Western blotting and monodansylcadaverine (MDC) labeled visualization.Results Proliferation of Hec-1A cells was obviously suppressed by nifedipine compared with that of the untreated cells for 24, 48, and 96 hours (P=0.000 for each day). The suppression of migration ability of the nifedipine-treated cells (94.0 +/- 8.2) was significantly different from that of the untreated cells (160.00 +/- 9.50, P=0.021). The level of early period cell apoptosis induced by nifedipine was (2.21 +/- 0.19)%, which was (2.90 +/- 0.13)% in control group (P=0.052), whereas the late period apoptosis level reached (10.38 +/- 0.96)% and (4.40 +/- 0.60)% (P=0.020), respectively. The 3-MA group induced a slight increase in the Cav1.3 levels within 15 minutes, but significantly attenuated the Cav1.3 levels after 30 minutes. There were more autophagic vacuoles labeled by MDC in the N group (20.63 +/- 3.36) than the control group (6.29 +/- 0.16, P=0.015). GFP-LC3 localization revealed that the LC3 levels of cells in 3-MA group, N+3MA group, 3-MA group were 2.80 +/- 0.29, 2.30 +/- 0.17, and 1.80 +/- 0.21, respectively. Cells in the N group showed significant augmentation of autophagy (P <0.05). Western blotting analysis confirmed the down-regulation of LC3 levels in 3-MA group (0.85 +/- 0.21) and N+3MA group (1.21 +/- 0.12) compared with nifedipine treatment (2.64 +/- 0.15, P <0.05). The annexin-V-FITC/PI assay showed that the level of early period cell apoptosis induced in the N+3-MA group ((11.22 +/- 0.91)%) differed significantly from that of the control group ((2.51 +/- 0.70)%) and N group ((3.47 +/- 0.39)%). Similarly, the late period level of the N+3-MA group ((55.19 +/- 2.51)%) differed significantly from that of the control group((15.81 +/- 1.36)%) and the N group ((22.09 +/- 2.48)%, P <0.05). The down-regulated expression of P70s6k and up-regulated expression of the Beclin1 revealed significant differences between the N+3-MA group and control group (P=0.025; Beclin1: P=0.015).Conclusions Proliferation and migration in vitro of endometrial carcinoma Hec-1A cells are significantly suppressed by nifedipine. The nifedipine leads autophagy to oppose Hec-1A cells apoptosis. Autophagy inhibition by 3-MA leads down-regulation of Cav1.3 and enhances nifedipine-induced cell death. The nifedipine-induced autophagy is linked to Beclin1 and mTOR pathways. Chin Med J 2012;125(17):3120-3126

miRNA omics reveal neferine induces apoptosis through Ca2+mediated endoplasmic reticulum stress pathway in human endometrial cancer

The Anti-Tumor Activities of Neferine on Cell Invasion and Oxaliplatin Sensitivity Regulated by EMT Via Snail Signaling in Hepatocellular Carcinoma.

Neferine, a novel ROCK1-targeting inhibitor, blocks EMT process and induces apoptosis in non-small cell lung cancer

Long Non-Coding RNA NNT-AS1 Positively Regulates NPM1 Expression to Affect the Proliferation of Estrogen-Mediated Endometrial Carcinoma by Interacting

The role of miR-34c-5p/Notch in epithelial-mesenchymal transition (EMT) in endometriosis

Neferine Induces Autophagy of Human Ovarian Cancer Cells Via P38 MAPK/ JNK Activation

Neferine-induced apoptosis is dependent on the suppression of Bcl-2 expression via downregulation of p65 in renal cancer cells

Azelnidipine Nanoparticles Break Calcium Homeostasis and Induce Severe ER Stress Combined with Medroxyprogesterone Acetate for Endometrial Cancer Therapy

Erianin Suppresses Endometrial Cancer Progression by Regulating the miR-661/BOK Axis

Suppressive Effect of Microrna-449A on the NDRG1/PTEN/AKT Axis Regulates Endometrial Cancer Growth and Metastasis

Lnc-Na Inhibits Proliferation And Metastasis In Endometrioid Endometrial Carcinoma Through Regulation Of Nr4a1

Advances in MiRNAs Involved in Endometrial Carcinoma

MicroRNA-182 Promotes Tumor Cell Growth by Targeting Transcription Elongation Factor A-like 7 in Endometrial Carcinoma

Study on the Effects of Neferine on MCF-7 Cells

Neferine inhibits the progression of diabetic nephropathy by modulating the miR-17-5p/nuclear factor E2-related factor 2 axis

lncRNA NBAT1 Inhibits Cell Metastasis and Promotes Apoptosis in Endometrial Cancer by Sponging miR-21-5p to Regulate PTEN

Nifedipine Induced Autophagy Through Beclin1 and Mtor Pathway in Endometrial Carcinoma Cells.

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

FAK and S6K1 Inhibitor, Neferine, Dually Induces Autophagy and Apoptosis in Human Neuroblastoma Cells

RelB/NF- κ B links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis

Integrating Bioinformatics and Experimental Validation to Identify Mitochondrial Permeability Transition-Driven Necrosis-Related lncRNAs that can Serve as Prognostic Biomarkers and Therapeutic Targets in Endometrial Carcinoma